Trial Profile
Efficacy and tolerability of an aromatase inhibitor (Anastrozole) therapy to limit the advance of bone maturation related to pathological adrenarche in children with Silver Russell or Prader Willi syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2019
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Acronyms ANASILPRA
- 07 Oct 2017 New trial record